Skip to main content
. 2019 Mar 15;17:84. doi: 10.1186/s12967-019-1809-3

Fig. 3.

Fig. 3

NST-1s suppresses necrotic cell death by decreasing the expression of receptor-interacting serine/threonine-protein kinase (RIPK)1, RIPK3, and mixed lineage kinase domain-like (pMLKL). Synovial tissue from CIA-induced control and NST-1s treated mice were subjected to immunohistochemical staining RIPK1, RIPK3, and pMLKL. The cells showing positively for RIPK1, RIPK3, and pMLKL were visually presented at a higher magnification. *p < 0.05; **p < 0.01; ***p < 0.001